View Exam | PowerPak

1. Which of the following statements about medication errors is false?

A. They are responsible for 10% of all deaths in the United States annually. B. They impact an estimated 1.5 million people every year. C. The morbidity and mortality associated with medication errors is estimated at $3.5 billion annually. D. Economics costs are not the only costs associated with medication errors.

2. Which of the following statements is true regarding medication errors?

A. Medication errors can occur at any stage of the medication use process. B. Medication errors are usually the fault of a single individual or event. C. Medication errors made by an individual should result in punitive action D. Medication errors only occur when the medicine is in control of a health professional

3. Regarding an institution's medication safety plan, which statement is false?

A. It should be comprehensive and strategic. B. It should be stewarded by a medication safety committee which has interdisciplinary representation. C. It should be led by a medication safety leader. D. It should only focus on quality improvement post-error occurrence.

4. Risk assessment can contribute to medication error prevention by:

A. Proactively identifying issues that may lead to errors B. Prioritizing issues to be addressed C. Driving critical, honest discussion of safety practices D. Creating an action plan for improvement E. All of the above

5. All of the following are ISMP tools designed for the acute care environment EXCEPT?

A. Medication Safety Self-Assessment ® for Hospitals B. Medication Safety Self-Assessment® for Infusion Centers C. Medication Safety Self-Assessment® for High-Alert Medications D. Assess-ERR™ Medication System Worksheets

6. Medication errors can occur throughout the medication use process. Which of the following aspects of the medication use process has the most commonly documented error rates based on an analysis of pharmacist liability claims in 2018?

A. Dispensing the wrong drug B. Dispensing the wrong dose C. Contamination of drug/container/equipment D. Giving the medication to the wrong patient

7. All of the following issues related to the medication management system can result in medication errors in the health system setting EXCEPT?

A. Failure to obtain patient's demographic and clinical information and appropriate medications upon admission. B. Not carefully labeling shelves, separating dosage forms, flagging high-risk medication and using TALL man letters to ensure best practice in drug storage, stock, standardization and distribution. C. Having standardized order sets and use of rule sets that minimize override ability in ADCs. D. Poor lighting, noise, interruptions and other environmental factors throughout the institution where medications are prepared, dispensed and/or administered.

8. Which of the following strategies has not been shown to reduce rates of medication errors?

A. Computerized physician order entry B. Barcode-assisted medication administration C. Use of smart pumps with medication libraries and guidelines that detect dose, concentration and administration rates D. Using internal data only on medication error patterns and safety risks as part of the medication safety quality improvement process.

9. Which of the following discharge-related activities can not help prevent medication errors?

A. Involving the pharmacist in medication reconciliation. B. Having patients pick up post-stay medications in the community rather than sending them at discharge. C. Education patients and caregivers on discharge medications, including any that have been discontinued and on medication name, purpose, appearance, dose, administration schedule, side effects and precautions. D. Engaging in a transition of care process in collaboration with community pharmacy providers.

10. Which statement is true about national medication error reporting programs?

A. They are required to be used when errors are discovered B. They are operated by the Secretary of Health and Human Services through the United States Pharmacopeia (USP) C. They are operated by ISMP and the FDA D. They are used to identify patterns in medication errors and create reports that provide important early warning systems and strategies to prevent medication errors in the future.